Frédéric Santer

University Assistant @ Department of Urology, Medical University of Innsbruck

[Frédéric Santer @FredSanter]

fantastic job from my PhD Student @jaspervgou on ARV7 splicing regulation and targeting in prostate cancer. check it out on @MolOncology https://t.co/bIqqKkm9zU

[Re-energising Your Career @career_re]

#AcademicTwitter Peer review hey! 😂😂#phdvoice #phdchat #FridayVibes
Image credit: @twisteddoodles

[Re-energising Your Career @career_re]

#AcademicTwitter This always makes me laugh! How long will yours take?😂😂@phdvoice #phdlife

[Anna Clemens, PhD @scientistswrite]

5 writing tips for an ⭐️excellent⭐️ Materials & Methods section

A thread. 🧵

#AcademicTwitter #Postdoc #newPI

—
#1: Provide the right amount of detail

✅ Read other papers in your target journal to get a feel for the level of detail that is common to provide

✅ Expand on all details that allow others to reproduce your experiments in the Supporting Information

—
#2: Use a storytelling structure

✅ Tell your readers the purpose of each of your experiments

—
#3 Structure your M&M section in the same way your Results section is structured

✅ Order your experiments as you you present them in the Result section

✅ Use equivalent subsection headings as in the Results section

—
#4 Refer to your Supporting Information in an organised way

✅ Clearly indicate where exactly the info can be found in the SI

✅ Use subsections and clear titles in the SI that make it easy to find the referred information

—
#5 Don't self-plagiarise

✅ Rewrite already published descriptions of your experiments

✅ Refer to previous publications for detailed descriptions of your method

—
TL;DR: 5 writing tips for an excellent Materials & Methods section ✨

1⃣ Provide the right amount of detail

2⃣ Use a storytelling structure

3⃣ Structure it like your Results section

4⃣ Refer to your Supporting Information in an organised way

5⃣ Don't self-plagiarise

[Reviewer 2 @GrumpyReviewer2]

#AcademicChatter #AcademicTwitter

[Frédéric Santer @FredSanter]

@FrancescaBZNY @paola_gasperini @cantore_thomas @CIBIO_UniTrento @FaltasLab @MariannKruithof @ERC_Research Congrats Riccardo!

[Anna Clemens, PhD @scientistswrite]

Are you and your co-authors editing the abstract of your paper again and again before submitting to get it just perfect?

👇 Use this template instead and save yourself hoursss!

A thread. 🧵

[Jen Heemstra @jenheemstra]

Genuinely caring about students should be a non-negotiable qualification for a career in academia. Full stop.

No amount of research achievement or creativity can substitute for caring about the professional development and well-being of those we teach and mentor.

[ÖGMBT-Young Life Scientists Austria @ogmbt_ylsa]

📢 Join us for the next Life Science Career Path organized by YLSA West!
🗓️ June 21
⏰ 5pm
🌍 Online (Zoom) + MedUni Innsbruck
🎓 Hear from Daniela Weiskopf, a distinguished professor in the USA, as she shares her career journey.
Register now: [email protected]
#LifeScience #YLSA

[Francesca Demichelis @FrancescaBZNY]

A terrific list of speakers at the #Pezcoller2023 symposium on New technologies for studying and treating cancer. An honor to introduce colleagues I have been following for years over many successes @XShirleyLiu @DaphneKoller @IdoAmitLab in #Trento

[Frédéric Santer @FredSanter]

Enjoying great talks #eacr2023 in Turin with @UroLab_ibk @imed_tweets

[Frédéric Santer @FredSanter]

https://t.co/Qoh12p8Xoq do genetic aberrations by isochromosome 12p formation in testicular cancer cause deregulation of vitamin D homeostasis? Check out our new publication together with Renate Pichler, @jaspervgou @UroLab_ibk @imed_tweets @Nutrients_MDPI

[Michelle Mitchell @Michelle_CRUK]

“Cigarettes are the one legal consumer product that, when used as intended, will kill most users.” A powerful read from @WalkerIan. https://t.co/OZXvNMRz4L

[Frédéric Santer @FredSanter]

@MarkARubin1 Thanks, interesting indeed. do you know by chance the frequency of germline BRCA mutations in the general population?

[Cancer Discovery @CD_AACR]

Just published! We proudly present "Hallmarks of Cancer: New Dimensions" by Douglas Hanahan, the third update to the seminal series. https://t.co/bSer4maIjF @Ludwig_Cancer

[Keller Lab @KellerLab]

It always feels like our academic publishing system is trapped in a kind of local minimum that is far away from an optimal solution. We know the things that are going wrong, but we still do by far too little to trigger real change.
https://t.co/rCuD8liuen via @wordpressdotcom

[The American Journal of Pathology @AJPathology]

MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors. Study by Assoc Editor Zoran Culig and co-authors @imed_tweets and @penn_state has implications for #prostatecancer therapy. FREE at https://t.co/LKP1jJbiof.

[Frédéric Santer @FredSanter]

A warm welcome to Jasper who will start his PhD in our lab under my supervision in a project funded by @FondationCancer @imed_tweets

[Frédéric Santer @FredSanter]

Happy to announce that a new project on ARV7 as a biomarker in prostate cancer has been granted by the Fondation Cancer Luxembourg. Check out the press announcement: https://t.co/lFY81kbmKi
@FondationCancer @imed_tweets